Archive

Adding obesity experts to primary care clinics improves patients’ weight loss outcomes

Written by | 24 May 2024

Giving high-risk patients access to an obesity specialist through their regular primary care clinic increased their chances of receiving at least one evidence-based weight-management treatment, and led to […]

ENDO 2024 press conferences to highlight male birth control, anti-obesity medications

Written by | 23 May 2024

Researchers will delve into emerging research in diabetes, obesity, reproductive health and other aspects of hormone health during the Endocrine Society’s ENDO 2024 news conferences June 1-4. The […]

Obese and overweight children at risk of iron deficiency

Written by | 21 Apr 2024

Children and young people who are overweight or obese are at significantly higher risk of iron deficiency, according to a study by nutritional scientists at the University of […]

This outdated diabetes drug still has something to offer

Written by | 17 Apr 2024

Thiazolidinediones (TZDs) are a class of drug that can be used to treat type 2 diabetes by reversing insulin resistance, one of the main hallmarks of the disease. […]

Very low calorie diets are safe and acceptable for teenagers with moderate to severe obesity when used short-term and supported by a dietitian, Australian study finds

Written by | 22 Mar 2024

Short-term very low calorie diets are safe for teenagers living with moderate to severe obesity when closely monitored by an experienced dietitian, new research to be presented at […]

One in five state Medicaid programs covers weight loss medications

Written by | 18 Mar 2024

Mounting evidence suggests that FDA-approved weight loss medications, such as Wegovy, not only help patients lose weight but also protect against complications from obesity such as cardiovascular disease. […]

High weekly physical activity levels linked to lower kidney disease risk in diabetes + overweight/obesity

Written by | 9 Feb 2024

Clocking up high weekly levels of moderate to vigorous intensity physical activity is linked to a lower risk of developing chronic kidney disease in overweight/obese people with type […]

New weight loss medication may help lower blood pressure in adults with obesity

Written by | 5 Feb 2024

The new weight loss medication tirzepatide significantly lowered the systolic blood pressure (the top number in a blood pressure reading) for nearly 500 adults with obesity who took […]

Science’s 2023 Breakthrough of the Year: GLP-1 agonists show promise for obesity-associated health problems

Written by | 21 Dec 2023

Science has named the development of glucagon like peptide-1 (GLP-1) agonists and this year’s discovery that these drugs can blunt obesity-associated health problems as its 2023 Breakthrough of The […]

Tirzepatide enhances weight loss with sustained treatment but discontinuation leads to weight regain

Written by | 15 Dec 2023

The current class of anti-obesity drugs is proving remarkably effective at removing excess pounds. However, a phase 3 randomized clinical trial led by researchers at Weill Cornell Medicine […]

Obesity associated with more severe disease flares in early rheumatoid arthritis

Written by | 29 Nov 2023

Obesity is associated with worse flare symptoms and worse quality of life among patients with early rheumatoid arthritis, researchers reported on Nov. 12, 2023 at ACR Convergence 2023, […]

Globally, consumption of sugary drinks increased at least 16% since 1990

Written by | 6 Oct 2023

The decision to reach for a sugary beverage is heavily influenced by where you live, Friedman School of Nutrition Science and Policy researchers report in a new study published October 3 in […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.